Introduction
Drugs : Drug is the chemical substance may be synthesized or derived naturally and is use for its therapeutic effect It plays a vital role in life it is meant to diagnose, mitigate, cure, prevent, or treat or modify the physiological condition. Drug is meant for the safeguard of public health.
Importance of the medicines: medicines are considered to be one of the vital need of the human being. One has to rely upon this once or oftenly in their life time in order to maintain their physical and mental health. In ancient times the illness was considered to be gods wish but after certain period the revolution came and now that is era and till date continuous introduction of drugs to the patient need is available. After continuous Discovery and introduction of the drug the public health is being improved. And the mortality rate compare to ancient time has been reduced.
But there are lot more risks are also associated with a drug along its benefits if not taken cautiously some of major among them are:
1. ADR(adverse drug reaction) 2 drug addiction 3. SAE(serious adverse event) 1 ADR(ADVERSE DRUG REACTION): it is some untoward reaction of a drug other than its therapeutic effects.
2. Drug addiction: these are those drugs also known as opioids drugs some times greatly required. But these drugs as the name suggested are habit forming.
3 SAE:this is known as serious adverse event may be associated with that particular medicine or may be by any other medicines but this event can lead to permanent disfuction of body or may even death of patient.
FDA and its role in drug approval
The food and drug administration in usa is the organization which responsible for approving and non. approving of the drug. the main aim of FDA is to keep uneffective and unsafe drugs off the market to ensure, protect and increase the good public health. just to ensure that the public good think that if the drug is approved it means it met all the standard for its safety and efficacy when a research molecule is researched then the pharmaceutical company file for IND(investigational new drug)to FDA. The IND filed by company contains whole data of preclinical study i.e trials performed on animals. The number of sheet would be around of 100000 pages in which the whole information about the new drug is written after reviewing the data if the criteria meets the standard then FDA gives approval for clinical trails for that particular drug. Each year FDA approve wide range of new drugs and biological products some of the products are new one or may be already in market but are seeking approval of FDA either for its other therapeutic effect or may be in combination to increase the efficacy.
In order to review the drug in proper way by the FDA the drugs are classified and the new innovative drug is considered to be as NEW MOLECULE ENTITY.
Following are the stages which a drug undergo with to come in market and at every and new stage the company has to file to FDA-:
1. Preclinical trials: inventing product are testing on animals 2. clinical trials-: Phase 1:perform on healthy volunteers to check the safety of product Phase 2: Perform on patients to check the safety and efficacy of product Phase 3 :perform on larger population of patient to make sure the safety and efficacy in larger population.
Phase-4:It is also known as post marketing of product done after launching of the product to market on periodic basis.
There are enormous numbers of the drugs which have been researched and many of these are in pipeline to come in market. it take a lot of time around 10-12 yrs it take to come a researched drug from lab to market. only 5 in 5000 drugs are approved for trials on human body after preclinical trial by FDA.
Reasons of not approving much drugs in recent time and then sudden increase in approvals
The industry and FDA both plays very important role in approval of a drug. There were a sudden decline in the approval of the drugs in past years because of the reason that the pharmaceutical company's r&d process that is they are not meeting the criteria for safety and efficacy and many other parameters which result into long term decline in pharmaceutical R&D productivity which ultimately led to decrease in probability of success and increased cost for discovery and development of drug. In order to avoid it the biopharmaceutical company taken the initiative to improve their r&d status and reducing their fixed costs by outsourcing it to CROS.
The average number of approval rate over time
From 2004-2012 CDER has 26 NME average approval per anum but in 2012 CDER had approved 39 NME and in 2013 it was 27. The number of approval of the drug remains steady and the maximum number of approval were in 2014 that is total 41 approval of novel drugs in past decades.
1. The reason for sudden increase in approving of new drugs is emergence of drug for life threating dieases through accelerated approval of drug from FDA.
2. the time reduce by FDA in reviewing data process for NME. 3. the inclination of pharmaceutical companies toward r&d requirement to meet the standard The innovative therapies approved in past few years given major advances in the field of oncology, cardiovascular disease, type 2 diabetes, hepatitis C and in HIV.
The novel drug of 2014-:
Following are the drugs approved by us-fda in 2014 LIST 
DCGI and its role in approving drugs
The drug controller general of india was established in 1998 the govt added schedule 'Y' to DRUG AND COSMETIC ACT-1940 scheduleY has detailed information for clinical trial and pre-clinical trials. However the pre-clinical trial is not approved in india. Though for the approval for the new drug to become approve and come in the market the same procedure like in us has to follow in india also. For the approval of the drug it is very necessary that the drug should meet all the criteria or guidelines provided in schedule Y. Then the application should be submitted to ethical committee. A clinical trial can only be performed after approval from DCGI for every next phase of the trial for the particular drug the application should be submitted to ethics committee and DCGI. DCGI is having the power to terminate the clinical trial in mid if the result or the data produce is not up to mark. In 2012 the pharmaceutical company were told to submit the safety report for the new drug in six months.
Drugs approved by DCGI in india 2014
The drugs approved by DCGI are mainly the drug which are already in market or approved already. They come in approval either in combination or with other therapeutic effect unlike previous or for further safety and efficacy purpose. Following are the drugs which were approved by dcgi in 
Conclusion
The revolution in drug discovery and its approval is proved as boon for public health. It results in improved health both mentally and physically in human race. The pace of drug approval is quite high in present time as compare to past few years. The high rate of approval of drug is good initiative by the government authorities to maintain and sustain good public health. Specially in case of life threatening illness like cancer, HIV, cardiovascular and many more. By approving these drugs on fast basis and keeping all quality and standard of these drugs in mind many lives can be saved in time. This is good move for both india and usa. Population. Specially in india as india is developing country and illness rate and variety of illness is more here than in any other country and due to lack of heigene and lack of awareness the chances are more to spread of dieases in contagious way specially in rural area. So it is very necessary demand for approval of these drugs so that preventive action can be taken against illness in time.
